MacroGenics
MGNX · NASDAQ
$3.49+$0.16 (+4.80%)TodayMarket closed ·
Prev close $3.33
EPS: actual vs estimate
Beat the estimate in 7 of the last 8 quarters, by 80.5% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.1283 | -$0.26 | −102.7% |
| Q1 FY26 | -$0.5826 | -$0.58 | +0.4% |
| Q4 FY25 | -$0.2964 | -$0.23 | +22.4% |
| Q3 FY25 | -$0.5015 | $0.27 | +153.8% |
| Q2 FY25 | -$0.6202 | -$0.57 | +8.1% |
| Q1 FY25 | -$0.7975 | -$0.65 | +18.5% |
| Q4 FY24 | -$0.4449 | -$0.25 | +43.8% |
| Q3 FY24 | $0.2162 | $0.90 | +316.3% |
Earnings calls
- Barclays 28th Annual Global Healthcare Conference
- Goldman Sachs 46th Annual Global Healthcare Conference 2025
- MGNX - Earnings call Q4 2024
- Barclays 27th Annual Global Healthcare Conference 2025
- MGNX - Earnings call Q3 2024
- Special Call - MacroGenics, Inc.
- Goldman Sachs 45th Annual Global Healthcare Conference
- MGNX - Earnings call Q1 2024
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.